
Raymond J. Henley Iii
Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1205, 2899, 1629, 1614, 1621 |
| Total Applications | 4324 |
| Issued Applications | 3034 |
| Pending Applications | 603 |
| Abandoned Applications | 710 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7436836
[patent_doc_number] => 20040002502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Medicament combinations comprising heterocyclic compounds and a novel anticholinergic'
[patent_app_type] => new
[patent_app_number] => 10/409402
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12726
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002502.pdf
[firstpage_image] =>[orig_patent_app_number] => 10409402
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/409402 | Medicament combinations comprising heterocyclic compounds and a novel anticholinergic | Apr 7, 2003 | Abandoned |
Array
(
[id] => 6830472
[patent_doc_number] => 20030181530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Soluble compositions of triphenylethylene antiestrogens'
[patent_app_type] => new
[patent_app_number] => 10/408321
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3862
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181530.pdf
[firstpage_image] =>[orig_patent_app_number] => 10408321
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/408321 | Soluble compositions of triphenylethylene antiestrogens | Apr 7, 2003 | Issued |
Array
(
[id] => 7136296
[patent_doc_number] => 20040044004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Calcium channel inhibitors comprising benzhydril spaced from piperazine'
[patent_app_type] => new
[patent_app_number] => 10/409868
[patent_app_country] => US
[patent_app_date] => 2003-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9635
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10409868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/409868 | Calcium channel inhibitors comprising benzhydril spaced from piperazine | Apr 7, 2003 | Issued |
Array
(
[id] => 1009457
[patent_doc_number] => 06900219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-31
[patent_title] => 'ABCA-1 elevating compounds'
[patent_app_type] => utility
[patent_app_number] => 10/407875
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18531
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/900/06900219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10407875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/407875 | ABCA-1 elevating compounds | Apr 3, 2003 | Issued |
Array
(
[id] => 7387393
[patent_doc_number] => 20040029907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Powder formulations containing tiotropium suitable for inhalation'
[patent_app_type] => new
[patent_app_number] => 10/406723
[patent_app_country] => US
[patent_app_date] => 2003-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3997
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10406723
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/406723 | Powder formulations containing tiotropium suitable for inhalation | Apr 2, 2003 | Issued |
Array
(
[id] => 6730854
[patent_doc_number] => 20030187044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Medicament'
[patent_app_type] => new
[patent_app_number] => 10/404345
[patent_app_country] => US
[patent_app_date] => 2003-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11842
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20030187044.pdf
[firstpage_image] =>[orig_patent_app_number] => 10404345
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/404345 | Medicament | Mar 31, 2003 | Abandoned |
Array
(
[id] => 1071998
[patent_doc_number] => 06841565
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-01-11
[patent_title] => 'Treatment of patients with chronic lymphocytic leukemia'
[patent_app_type] => utility
[patent_app_number] => 10/403667
[patent_app_country] => US
[patent_app_date] => 2003-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6335
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/841/06841565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10403667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/403667 | Treatment of patients with chronic lymphocytic leukemia | Mar 30, 2003 | Issued |
Array
(
[id] => 7437391
[patent_doc_number] => 20040002537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Use of statins in the treatment of autoimmune disease'
[patent_app_type] => new
[patent_app_number] => 10/404922
[patent_app_country] => US
[patent_app_date] => 2003-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6629
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20040002537.pdf
[firstpage_image] =>[orig_patent_app_number] => 10404922
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/404922 | Use of statins in the treatment of autoimmune disease | Mar 30, 2003 | Abandoned |
Array
(
[id] => 7401405
[patent_doc_number] => 20040019036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Treatment of chronic myelogenous leukemia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents'
[patent_app_type] => new
[patent_app_number] => 10/397267
[patent_app_country] => US
[patent_app_date] => 2003-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10148
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20040019036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10397267
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/397267 | Treatment of chronic myelogenous leukmia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other agents | Mar 26, 2003 | Issued |
Array
(
[id] => 679125
[patent_doc_number] => 07083779
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis'
[patent_app_type] => utility
[patent_app_number] => 10/397967
[patent_app_country] => US
[patent_app_date] => 2003-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8807
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/083/07083779.pdf
[firstpage_image] =>[orig_patent_app_number] => 10397967
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/397967 | Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis | Mar 25, 2003 | Issued |
Array
(
[id] => 1170012
[patent_doc_number] => 06753350
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-06-22
[patent_title] => 'Method to reduce the incidence of intraventricular hemorrhage in preterm infants'
[patent_app_type] => B1
[patent_app_number] => 10/395356
[patent_app_country] => US
[patent_app_date] => 2003-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13644
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/753/06753350.pdf
[firstpage_image] =>[orig_patent_app_number] => 10395356
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/395356 | Method to reduce the incidence of intraventricular hemorrhage in preterm infants | Mar 23, 2003 | Issued |
Array
(
[id] => 6805463
[patent_doc_number] => 20030232857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Chronic, bolus administration of D-threo methylphenidate'
[patent_app_type] => new
[patent_app_number] => 10/395444
[patent_app_country] => US
[patent_app_date] => 2003-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5375
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232857.pdf
[firstpage_image] =>[orig_patent_app_number] => 10395444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/395444 | Chronic, bolus administration of D-threo methylphenidate | Mar 23, 2003 | Abandoned |
Array
(
[id] => 6639085
[patent_doc_number] => 20030212004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis'
[patent_app_type] => new
[patent_app_number] => 10/380763
[patent_app_country] => US
[patent_app_date] => 2003-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2781
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10380763
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/380763 | Therapeutic use of aerosolized S-nitrosoglutathione in cystic fibrosis | Mar 23, 2003 | Issued |
Array
(
[id] => 7233332
[patent_doc_number] => 20050256086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Fosinopril formulation'
[patent_app_type] => utility
[patent_app_number] => 10/507918
[patent_app_country] => US
[patent_app_date] => 2003-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1161
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20050256086.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507918 | Fosinopril formulation | Mar 18, 2003 | Issued |
Array
(
[id] => 6835283
[patent_doc_number] => 20030162829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Combination of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor'
[patent_app_type] => new
[patent_app_number] => 10/390517
[patent_app_country] => US
[patent_app_date] => 2003-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16593
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10390517
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/390517 | Combination of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor | Mar 16, 2003 | Abandoned |
Array
(
[id] => 6939720
[patent_doc_number] => 20050113283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Methods of treating conditions associated with an EDG-4 receptor'
[patent_app_type] => utility
[patent_app_number] => 10/390429
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 33675
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113283.pdf
[firstpage_image] =>[orig_patent_app_number] => 10390429
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/390429 | Methods of treating conditions associated with an EDG-4 receptor | Mar 13, 2003 | Abandoned |
Array
(
[id] => 6906123
[patent_doc_number] => 20050101518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Methods of treating conditions associated with an EDG-2 receptor'
[patent_app_type] => utility
[patent_app_number] => 10/390427
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22682
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10390427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/390427 | Methods of treating conditions associated with an EDG-2 receptor | Mar 13, 2003 | Abandoned |
Array
(
[id] => 5051914
[patent_doc_number] => 20070032459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-08
[patent_title] => 'METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG-3 RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 10/390426
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20596
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20070032459.pdf
[firstpage_image] =>[orig_patent_app_number] => 10390426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/390426 | Methods of treating conditions associated with an Edg-3 receptor | Mar 13, 2003 | Issued |
Array
(
[id] => 7011493
[patent_doc_number] => 20050065209
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Citalopram for the treatment of elevated blood pressure'
[patent_app_type] => utility
[patent_app_number] => 10/489179
[patent_app_country] => US
[patent_app_date] => 2003-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2798
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065209.pdf
[firstpage_image] =>[orig_patent_app_number] => 10489179
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/489179 | Citalopram for the treatment of elevated blood pressure | Mar 12, 2003 | Issued |
Array
(
[id] => 961177
[patent_doc_number] => 06951890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-04
[patent_title] => 'Preventing and/or treating cardiovascular disease and/or associated heart failure'
[patent_app_type] => utility
[patent_app_number] => 10/388213
[patent_app_country] => US
[patent_app_date] => 2003-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 32697
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/951/06951890.pdf
[firstpage_image] =>[orig_patent_app_number] => 10388213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/388213 | Preventing and/or treating cardiovascular disease and/or associated heart failure | Mar 11, 2003 | Issued |